Open Label Study of the Effect of GTx-758 on Serum PSA and Free Testosterone Levels in Men With Castration Resistant Prostate Cancer and Maintained on Androgen Deprivation Therapy.
Phase of Trial: Phase II
Latest Information Update: 14 Nov 2013
At a glance
- Drugs GTx 758 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors GTx
- 10 Jun 2017 Biomarkers information updated
- 04 Apr 2012 Planned end date (1 Sep 2013) added as reported by ClinicalTrials.gov.
- 08 Mar 2012 Actual patient number 8 added as reported by ClinicalTrials.gov.